Summit Therapeutics Inc. - Common Stock (SMMT)
$18.11
0.73 (3.87%)
SMMT Stock Earnings: Summit Therapeutics Beats EPS for Q2 2024
SMMT stock results show that Summit Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.76B
PE Ratio
-56.59
EPS
-0.32
Volume (Avg. Vol.)
3.73M
Day's Range
$17.70 - $19.20
52-Week Range
$2.10 - $33.89
Dividend & Yield
N/A (N/A)